Watch CYTK. Know when insiders buy.
One email the day a filing lands. Free.
Work order
30
FLAG · insiders 25, shorts 34
Insiders, 90 days
−$1.6M
net selling · 0 buys, 3 sells
Congress, 90 days
1 / 0
buys / sells · latest disclosed Jul 2
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $10.3BP/E —DIV YIELD —FCF YIELD -5.65%REV TTM $67.7M −21.1%NET INCOME −$894MNET DEBT $746.6M52W 47.56 – 87.26SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $28.6M | −57.1% | — | −$179.2M | −$198.8M | — | -1.50 | −$159.8M | $4.3M | −$164.2M | Aug 6 |
| Q1 2026 · Mar 31 | $19.4M | +1125.8% | — | −$183.6M | −$206M | — | -1.67 | −$145.5M | $5.9M | −$151.4M | Aug 6 |
| Q4 2025 · Dec 31derived | $17.8M | +4.9% | — | −$178.4M | −$183M | — | -1.50 | −$142.7M | $5.6M | −$148.3M | Feb 26 |
| Q3 2025 · Sep 30 | $1.9M | +318.1% | — | −$166.8M | −$306.2M | — | -2.55 | −$107.5M | $9.4M | −$116.9M | Nov 5 |
| Q2 2025 · Jun 30 | $66.8M | +26714.9% | — | −$111.5M | −$134.4M | — | -1.12 | −$128.2M | $4.1M | −$132.4M | Aug 6 |
| Q1 2025 · Mar 31 | $1.6M | +89.1% | — | −$155.6M | −$161.4M | — | -1.36 | −$131.6M | $5.7M | −$137.3M | Aug 6 |
| Q4 2024 · Dec 31derived | $16.9M | +912.4% | — | −$139M | −$150M | — | -1.26 | −$65.6M | $1.3M | −$66.9M | Feb 26 |
| Q3 2024 · Sep 30 | $463K | +22.5% | — | −$140.8M | −$160.5M | — | -1.36 | −$101.5M | $701K | −$102.2M | Nov 5 |
| Q2 2024 · Jun 30 | $249K | — | — | −$130.2M | −$143.3M | — | -1.31 | −$99.3M | $1.9M | −$101.2M | Nov 5 |
| Q1 2024 · Mar 31 | $835K | — | — | −$126.2M | −$135.6M | — | -1.33 | −$129.5M | $0 | −$129.5M | Nov 5 |
| Q4 2023 · Dec 31derived | $1.7M | — | — | −$127.4M | −$136.9M | — | -1.38 | −$74M | $77K | −$74.1M | Feb 26 |
| Q3 2023 · Sep 30 | $378K | — | — | −$122.3M | −$129.4M | — | -1.35 | −$96.2M | $220K | −$96.4M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $88M | — | −$612.3M | −$785M | -891.6% | -6.54 | −$510M | $24.8M | −$534.8M | — | — |
| FY2024 · to Dec 31 | $18.5M | — | −$536.2M | −$589.5M | -3191.1% | -5.26 | −$395.9M | $3.9M | −$399.8M | — | — |
| FY2023 · to Dec 31 | $7.5M | — | −$496.2M | −$526.2M | -6988.6% | -5.45 | −$414.3M | $1.4M | −$415.7M | — | — |
| FY2022 · to Dec 31 | $94.6M | — | −$324.2M | −$389M | -411.2% | -4.33 | −$299.5M | $11.3M | −$310.9M | — | — |
| FY2021 · to Dec 31 | $70.4M | — | −$186.3M | −$215.3M | -305.7% | -2.80 | −$142.5M | $48.9M | −$191.4M | — | — |
| FY2020 · to Dec 31 | $55.8M | — | −$93.9M | −$127.3M | -228.0% | -1.97 | $8.9M | $11.1M | −$2.1M | — | — |
Every number comes from CYTOKINETICS INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.